NanoVibronix, Inc.
NAOV
$5.80
-$0.09-1.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -30.66% | -6.60% | 12.05% | 227.79% | 424.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -30.66% | -6.60% | 12.05% | 227.79% | 424.57% |
| Cost of Revenue | 32.97% | 63.91% | 40.75% | 163.69% | 190.05% |
| Gross Profit | -65.56% | -38.30% | -1.89% | 292.40% | 842.86% |
| SG&A Expenses | 69.15% | 10.62% | -5.58% | -17.30% | -13.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.72% | 38.41% | 14.57% | 7.33% | 5.39% |
| Operating Income | -262.38% | -87.95% | -16.45% | 42.50% | 52.00% |
| Income Before Tax | -215.66% | -76.29% | -0.11% | 38.04% | 45.89% |
| Income Tax Expenses | 240.00% | -20.59% | -34.48% | 66.67% | -7.41% |
| Earnings from Continuing Operations | -215.87% | -75.27% | 0.16% | 37.72% | 45.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -215.87% | -75.27% | 0.16% | 37.72% | 45.69% |
| EBIT | -262.38% | -87.95% | -16.45% | 42.50% | 52.00% |
| EBITDA | -245.54% | -87.25% | -16.47% | 42.51% | 52.00% |
| EPS Basic | 14.54% | 20.62% | 43.97% | 60.53% | 61.60% |
| Normalized Basic EPS | -6.63% | 9.80% | 38.55% | 64.03% | 64.81% |
| EPS Diluted | 14.54% | 20.62% | 43.97% | 60.53% | 61.60% |
| Normalized Diluted EPS | -6.63% | 9.80% | 38.55% | 64.03% | 64.81% |
| Average Basic Shares Outstanding | 626.59% | 101.09% | 72.17% | 58.04% | 48.58% |
| Average Diluted Shares Outstanding | 626.59% | 101.09% | 72.17% | 58.04% | 48.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |